ExploreWatchlistsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. Proceeds from issuance of term debt, net

Edwards Lifesciences Corp (EW)

Market cap
$45.9B
P/E ratio
43.2x
SummaryFinancials
Period EndProceeds from issuance of term debt, net (Million USD)YoY (%)
Dec 31, 20215-67.90%
Dec 31, 202016-14.29%
Dec 31, 201919-97.25%
Dec 31, 2018688-30.83%
Dec 31, 2017995+292.39%
Dec 31, 2016254+707.32%
Dec 31, 201531-86.12%
Dec 31, 2014226-82.66%
Dec 31, 20131,305

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat